Publications by authors named "Sara Matar"

Claim this Profile
S
Safety, Cognitive, and Behavioral Outcomes in Patients with Dementia with Lewy Bodies Treated with Nilotinib.
Fernando Pagan, Yasar Torres-Yaghi, Michaeline Hebron, Barbara Wilmarth, R Scott Turner, Sara Matar

J Clin Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19.
Ziad Bakouny, Chris Labaki, Punita Grover, Joy Awosika, Shuchi Gulati, Sara Matar

JAMA Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alteration of Autophagy and Glial Activity in Nilotinib-Treated Huntington's Disease Patients.
Karen E Anderson, Max Stevenson, Rency Varghese, Michaeline L Hebron, Erin Koppel, Sara Matar

Metabolites· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, target engagement, and biomarker effects of bosutinib in dementia with Lewy bodies.
Fernando L Pagan, Yasar Torres-Yaghi, Michaeline L Hebron, Barbara Wilmarth, R Scott Turner, Sara Matar

Alzheimers Dement (N Y)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Safety and Clinical Effects of Nilotinib in Parkinson's Disease.
Fernando L Pagan, Barbara Wilmarth, Yasar Torres-Yaghi, Michaeline L Hebron, Sanjana Mulki, Sara Matar

Mov Disord· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nilotinib Effects on Safety, Tolerability, and Biomarkers in Alzheimer's Disease.
Raymond S Turner, Michaeline L Hebron, Abigail Lawler, Elizabeth E Mundel, Nadia Yusuf, Sara Matar

Ann Neurol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease: A Phase 2 Randomized Clinical Trial.
Fernando L Pagan, Michaeline L Hebron, Barbara Wilmarth, Yasar Torres-Yaghi, Abigail Lawler, Sara Matar

JAMA Neurol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parvovirus B19-induced hemophagocytic lymphohistiocytosis: Case report and review of the literature.
James Kalmuk, Sara Matar, Gong Feng, Edward Kilb, Ming Y Lim

Clin Case Rep· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and pharmacodynamics of a single dose Nilotinib in individuals with Parkinson's disease.
Fernando L Pagan, Michaeline L Hebron, Barbara Wilmarth, Yasar Torres-Yaghi, Abigail Lawler, Sara Matar

Pharmacol Res Perspect· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in immunotherapy for melanoma management.
Mohammed Dany, Rose Nganga, Alissar Chidiac, Edith Hanna, Sara Matar

Hum Vaccin Immunother· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis